Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 33.12M P/E - EPS this Y 3.60% Ern Qtrly Grth -
Income -5.3M Forward P/E -6.14 EPS next Y -11.10% 50D Avg Chg 4.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 141.00%
Dividend N/A Price/Book 5.46 EPS next 5Y - 52W High Chg -80.00%
Recommedations 3.00 Quick Ratio 9.25 Shares Outstanding 19.26M 52W Low Chg 713.00%
Insider Own 9.71% ROA -54.32% Shares Float 16.68M Beta 1.88
Inst Own 8.15% ROE -95.14% Shares Shorted/Prior 214.45K/170.16K Price 1.78
Gross Margin - Profit Margin - Avg. Volume 803,680 Target Price 2.20
Oper. Margin - Earnings Date Mar 18 Volume 441,574 Change -5.82%
About Virios Therapeutics, Inc.

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

Virios Therapeutics, Inc. News
05/02/24 Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
03/26/24 Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
02/29/24 Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
02/28/24 Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
02/07/24 VIRI: Moving IMC-2 into Phase 2 Program in Long COVID
01/22/24 Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
01/02/24 Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID
11/14/23 Virios Therapeutics, Inc. (NASDAQ:VIRI) Q3 2023 Earnings Call Transcript
11/13/23 VIRI: Provides Overview of Phase 3 Program in Fibromyalgia
11/13/23 Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
11/06/23 Virios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
10/12/23 Virios Therapeutics to Present at the ThinkEquity Conference on Thursday, October 19, 2023
09/18/23 Virios Therapeutics Announces Termination of At-The-Market Sales Agreement
09/12/23 Virios Therapeutics CEO Greg Duncan to Present at the SHARE™️ Series Investor Event on Monday, September 18, 2023
08/15/23 VIRI: Phase 3 Program in Fibromyalgia to Initiate in mid-2024…
08/14/23 Virios Therapeutics Announces Halt to At-The-Market Offering Sales
08/12/23 Virios Therapeutics, Inc. (NASDAQ:VIRI) Q2 2023 Earnings Call Transcript
08/10/23 Virios Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
08/09/23 Virios Therapeutics Announces Plans to Advance Lead Candidate IMC-1 to Phase 3 Development as a New Treatment Option for Fibromyalgia
08/03/23 Virios Therapeutics to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
VIRI Chatroom

User Image GoodDreams Posted - 10 minutes ago

$VIRI Earning Tomorrow May 9th Pre Market?

User Image Hoodedmenace Posted - 38 minutes ago

$VIRI let’s see what tomorrow has to bring longs

User Image DonDeutsch Posted - 1 hour ago

$VIRI

User Image ByBi Posted - 8 hours ago

$VIRI they must anticipate positive results. 👀👇

User Image johnny6nine Posted - 22 hours ago

$VIRI will seek extension from nasdaq. Has a plan to regain compliance without r/s

User Image 123lockbox_ Posted - 1 day ago

$VIRI This thing like a road side chilli stand. Can’t hold shiiiiit.

User Image TU6637 Posted - 1 day ago

$VIRI it’s up 11%

User Image ByBi Posted - 1 day ago

$VIRI fun fact, they kept most of their investors from inception. 131 holders as of feb. 2024. But still too many to share my pie with. You guys need to sell. 🤷🏼‍♂️

User Image RealAvidTrader Posted - 1 day ago

$CDTX $CDXC $VIRI 🚀 Earnings Catalysts Could Make These Stocks Rocket 🚀 https://youtu.be/b1jLKdCDW2A

User Image Andrew6666 Posted - 2 days ago

$VIRI What a disaster . I have never been invested in a scam Company like this. Every day down. I Will write off my investment to zero. It can happen in Life 🤷

User Image Diamond_dog Posted - 2 days ago

$VIRI this ticker is a fkn joke. Feeling like I’m wasting my time and $ here.

User Image Johnstonj27 Posted - 2 days ago

$VIRI Wow, everything moving up today!!! VIRI wake the Fuk UP!

User Image Limer_814 Posted - 2 days ago

$VIRI May 9th call , corporate update..let's see how that goes..

User Image jamersonmoody Posted - 5 days ago

$VIRI I hope another pump and dump happens before an RS. To at least get some people out of here.

User Image Johnstonj27 Posted - 5 days ago

$VIRI Greg, Awesome Volume here Thanks!!! for your dropping a r/s vote when was days away from compliance. Now dark clouds hanging over all the great work in your two drug trials. Just Amazing...

User Image johnny6nine Posted - 5 days ago

$VIRI waiting on VIRI to make a $EYEN type move….

User Image johnny6nine Posted - 5 days ago

$VIRI Greg…. You promised a partnership update by the end of the quarter?? Come on grease ball. Make a deal.

User Image The_Claw Posted - 5 days ago

$VIRI Good grief, Viri, this is getting a little ridiculous. I’ve learned my lesson about taking profits!

User Image jamersonmoody Posted - 6 days ago

$VIRI i have a feeling this goes under .40 soon. Probably will be a RS at some point and then drop to all time lows and then do an offering. That’s how companies like this survive. Too bad Greg didn’t know how to keep his stupid mouth shut and killed momentum. Dickhead.

User Image DonDeutsch Posted - 6 days ago

$VIRI

User Image Stock_Titan Posted - 6 days ago

$VIRI Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 https://www.stocktitan.net/news/VIRI/virios-therapeutics-to-report-first-quarter-2024-financial-results-q7p6gqudbqga.html

User Image NMWOLF Posted - 6 days ago

$VIRI $ETAO $GPAK $XTLB

User Image Johnstonj27 Posted - 6 days ago

$VIRI Jim Cramer will probably focus on VIRI sometime this week hot volume stock. lol

User Image jamersonmoody Posted - 1 week ago

$VIRI Greg fired yet?

User Image Andrew6666 Posted - 1 week ago

$VIRI Not compliant. Price 0,43 volume almost zero. Disgusting.

User Image AllAmerican82ndAirborne Posted - 1 week ago

$VIRI

User Image Drainomight Posted - 1 week ago

$VIRI

User Image DonDeutsch Posted - 04/30/24

$VIRI ...

User Image tt9kal Posted - 04/30/24

$VIRI Some people say that red without volume means nothing, but does it mean nothing if $2.4 is $0.4 because of its continuation? Maybe he has not yet noticed that the stock price has gone down 1/6th of a percent.

User Image BigStockG Posted - 04/30/24

$VIRI Who in the hell is Swinging PENNIES???????😭

Analyst Ratings
HC Wainwright & Co. Neutral Sep 20, 22
HC Wainwright & Co. Buy Dec 15, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Duncan Gregory Scott CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Aug 17 Buy 1.2498 25,000 31,245 57,461 08/18/23
Whitley Richard James Director Director Dec 08 Sell 0.2591 1,800 466 700 12/12/22
Walsh Angela SVP OF FINANCE SVP OF FINANCE May 23 Buy 4.575 2,000 9,150 3,000 05/24/22
Duncan Gregory Scott CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 23 Buy 4.52 7,500 33,900 32,461 05/24/22
Pridgen William Director Director May 17 Buy 4.3802 13,450 58,914 36,469 05/18/22
Pridgen William Director Director Mar 29 Buy 4.9408 600 2,964 23,019 03/30/22
Pridgen William Director Director Mar 23 Buy 5.4627 2,197 12,002 22,419 03/24/22
De La Rosa Abel Director Director Jan 07 Buy 5.896 4,000 23,584 4,000 01/07/22